Acetylation and deacetylation - Novel factors in muscle wasting

Metabolism: Clinical and Experimental

Volumn 62, Issue 1, 2013, Pages 1-11

  Alamdari, Nima ^a   Aversa, Zaira ^a   Castillero, Estibaliz ^a   Hasselgren, Per Olof ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Histone acetyl transferases; Histone deacetylases; Muscle atrophy; Nuclear factors; p300; SIRT1; Transcription factors

Indexed keywords

CELL PROTEIN; CHAPERONE; E1A ASSOCIATED P300 PROTEIN; GLUCOCORTICOID; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; HISTONE DEACETYLASE 6; NUCLEAR FACTOR; SIRTUIN 1; TRANSCRIPTION FACTOR; UBIQUITIN PROTEIN LIGASE;

ACETYLATION; CATABOLISM; DEACETYLATION; DISSOCIATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; IMMOBILIZATION; MUSCLE ATROPHY; MUSCLE DENERVATION; MUSCLE MASS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REVIEW; SEPSIS; SKELETAL MUSCLE; TRANSCRIPTION REGULATION;

ACETYLATION; HISTONE ACETYLTRANSFERASES; HISTONE DEACETYLASES; HUMANS; MUSCLE PROTEINS; MUSCLE, SKELETAL; MUSCULAR ATROPHY;

EID: 84870878023     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2012.03.019     Document Type: Review

References (115)

1. P.O. Hasselgren, M.J. Menconi, and M.U. Fareed Novel aspects on the regulation of muscle wasting in sepsis Int J Biochem Cell Biol 37 2005 2156 2168
2. S.H. Lecker, A.L. Goldberg, and W.E. Mitch Protein degradation by the ubiquitin-proteasome pathway in normal and disease states J Am Soc Nephrol 17 2006 1807 1819
3. M.G. Jeschke, D.L. Chinkes, and C.C. Finnerty Pathophysiologic response to severe burn injury Ann Surg 248 2008 387 401
4. M.J. Tisdale Mechanisms of cancer cachexia Physiol Rev 89 2009 381 410
5. M. Sandri Autophagy in health and disease. 3. Involvement of autophagy in muscle atrophy Am J Physiol Cell Physiol 298 2010 C1291 C1297
6. T.K. Roberts-Wilson, R.N. Reddy, and J.L. Bailey Calcineurin signaling and PGC-1α expression are suppressed during muscle atrophy due to diabetes Biochim Biophys Acta 1803 2010 960 967
7. M. Muscaritoli, A. Molfino, and M.R. Bollea Malnutrition and wasting in renal disease Curr Opin Clin Nutr Metab Care 12 2009 378 383
8. L.A. Callahan, and G.S. Supinski Sepsis-induced myopathy Crit Care Med 37 2009 S354 S367
9. W.D. Schweikert, and J. Hall ICU-acquired weakness Chest 131 2007 1541 1549
10. M. Visser, and L.A. Schaap Consequences of sarcopenia Clin Geriatr Med 27 2011 387 399
11. E.J. Yang, S. Lim, and Y. Lim Association between muscle strength and metabolic syndrome in older Korean men and women: the Korean longitudinal study on health and aging Metabolism 61 2012 317 324
12. B. De Jonghe, S. Bastuji-Garin, and M.C. Durand Respiratory weakness is associated with limb weakness and delayed weaning in critical illness Crit Care Med 35 2007 2007 2015
13. S. Levine, T. Nguyen, and N. Taylor Rapid disuse atrophy of diaphragm fibers in mechanically ventilated humans N Engl J Med 358 2008 1327 1335
14. P.O. Hasselgren Ubiquitination, phosphorylation, and acetylation - triple threat in muscle wasting J Cell Physiol 213 2007 679 689
15. S. Lunke, and A. El-Osta The emerging role of epigenetic modifications and chromatin remodeling in spinal muscular atrophy J Neurochem 109 2009 1557 1569
16. H. Yang, M.J. Menconi, and W. Wei Dexamethasone upregulates the expression of the nuclear cofactor p300 and its interaction with C/EBPβ in cultured myotubes J Cell Biochem 94 2005 1058 1067
17. H. Yang, W. Wei, and M. Menconi Dexamethasone-induced protein degradation in cultured myotubes is p300/HAT dependent Am J Physiol Regul Integr Comp Physiol 292 2007 R337 R344
18. K. Tobimatsu, T. Noguchi, and T. Hosooka Overexpression of the transcriptional coregulator Cited2 protects against glucocorticoid-induced atrophy of C2C12 myotubes Biochem Biophys Res Commun 378 2009 399 403
19. N. Alamdari, I.J. Smith, and Z. Aversa Sepsis and glucocorticoids upregulate p300 and downregulate HDAC6 expression and activity in skeletal muscle Am J Physiol Regul Integr Comp Physiol 299 2010 R509 R520
20. T. Kouzarides Acetylation: a regulatory modification to rival phosphorylation? EMBO J 19 2000 1176 1179
21. R.N. Freiman, and R. Tjian Regulating the regulators: lysine modifications make their mark Cell 112 2003 11 17
22. L. Wang, Y. Tang, and P.A. Cole Structure and chemistry of the p300/CBP and Rtt 109 histone acetyltransferases: implications for acetyltransferase evolution and function Curr Opin Struct Biol 18 2008 741 747
23. X.J. Yang, and E. Seto Lysine acetylation: codified crosstalk with other posttranslational modifications Mol Cell 31 2008 449 461
24. C.D. Allis, S.L. Berger, and J. Cote New nomenclature for chromatin-modifying enzymes Cell 131 2007 633 636
25. T.A. McKinsey, C.L. Zhang, and E.N. Olson Control of muscle development by dueling HATs and HDACs Curr Opin Genet Dev 11 2001 497 504
26. L.F. Chen, and W.C. Greene Regulation of distinct biological activities of the NF-kB transcription factor complex by acetylation J Mol Med 81 2003 549 557
27. V. Perrot, and M.M. Rechler The coactivator p300 directly acetylates the forkhead transcription factor Foxo1 and stimulates Foxo1-induced transcription Mol Endocrinol 19 2005 2283 2298
28. T.I. Cesena, J.R. Cardinaux, and R. Kwok CCAAT/enhancer-binding protein (C/EBP)β is acetylated at multiple lysines. Acetylation of C/EBPβ at lysine 39 modulates its ability to activate transcription J Biol Chem 282 2007 956 967
29. Z. Gerhart-Hines, J.T. Rodgers, and O. Bare Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1α EMBO J 26 2007 1913 1923
30. X. Liu, L. Wang, and K. Zhao The structural basis of protein acetylation by the p300/CBP transcriptional coactivator Nature 451 2008 846 850
31. M. Ott, and E. Verdin HAT trick: p300, small molecule, inhibitors Chem Biol 17 2010 417 418
32. A.J.M. DeRuijter, A.H. van Gennip, and H.N. Caron Histone deacetylases (HDACs): characterization of the classical HDAC family Biochem J 370 2003 737 749
33. J.C. Black, A. Mosley, and T. Kitada The SIRT2 deacetylase regulates autoacetylation of p300 Mol Cell 32 2008 449 455
34. Y. Han, Y.H. Jin, and Y.J. Kim Acetylation of Sirt2 by p300 attenuates its deacetylase activity Biochem Biophys Res Commun 375 2008 576 580
35. C. Caron, C. Boyault, and S. Khochbin Regulatory cross-talk between lysine acetylation and ubiquitination: role in the control of protein stability Bioessays 27 2005 408 415
36. K. Sadoul, C. Boyault, and M. Pabion Regulation of protein turnover by acetyltransferases and deacetylases Biochim 90 2008 306 312
37. J.W. Jeong, M.K. Bae, and M.Y. Ahn Regulation and destabilization of HIF-1α by ARD1-mediated acetylation Cell 111 2002 709 720
38. T. Shimazu, Y. Komatsu, and K.I. Nakayama Regulation of SV40 large T-antigen stability by reversible acetylation Oncogene 25 2006 7391 7400
39. C. Leduc, P. Claverie, and B. Eymin p14ARF promotes RB accumulation through inhibition of its Tip60-dependent acetylation Oncogene 25 2006 4147 4154
40. W. Chamberlain, P. Gonnella, and N. Alamdari Multiple muscle wasting-related transcription factors are acetylated in dexamethasone-treated muscle cells Biochem Cell Biol 90 2012 200 208
41. Y. Zhao, J. Yang, and W. Liao Cytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activity Nat Cell Biol 12 2010 665 675
42. S.R. Grossman, M.E. Deato, and C. Brignone Polyubiquitination of p53 by a ubiquitin ligase activity of p300 Science 300 2003 342 344
43. L.K. Linares, R. Kiernan, and R. Triboulet Intrinsic ubiquitination activity of PCAF controls the stability of the oncoprotein Hdm2 Nat Cell Biol 9 2007 331 338
44. A.S. Turnell, G.S. Stewart, and R.J. Grand The APC/C and CBP/p300 cooperate to regulate transcription and cell cycle progression Nature 438 2005 690 695
45. D. Seigneurin-Berney, A. Verdel, and S. Curtet Identification of components of the murine histone deacetylase 6 complex: link between acetylation and ubiquitination signaling pathways Mol Cell Biol 21 2001 8035 8044
46. P. Bali, M. Pranpat, and J. Bradner Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: a novel basis for antileukemia activity of histone deacetylase inhibitors J Biol Chem 280 2005 26729 26734
47. B.T. Scroggins, K. Robzyk, and D. Wang An acetylation site in the middle domain of Hsp90 regulates chaperone function Mol Cell 25 2007 151 159
48. M. Simonsson, C.H. Heldin, and J. Ericsson The balance between acetylation and deacetylation controls Smad7 stability J Biol Chem 280 2005 21797 21803
49. M. Yoshida, A. Matsuyama, and Y. Komatsu From discovery to the coming generation of histone deacetylase inhibitors Curr Med Chem 10 2003 2351 2358
50. S. Minucci, and P.G. Pelicci Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer Nat Rev Cancer 6 2006 38 51
51. S.H. Kim, H.J. Kang, and H. Na Trichostatin A enhances acetylation as well as protein stability of ERα through induction of p300 protein Breast Cancer Res 12 2010 R22
52. D. Cai, J.D. Frantz, and N.E. Tawa IKKβ/NF-kB activation causes severe muscle wasting in mice Cell 119 2004 285 298
53. M. Sandri, C. Sandri, and A. Gilbert Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy Cell 117 2004 399 412
54. D.S. Waddell, L.M. Baehr, and J. van den Brandt The glucocorticoid receptor and FOXO1 synergistically activate the skeletal muscle atrophy-associated MuRF1 gene Am J Physiol Endocrinol Metab 295 2008 E785 E797
55. S. Usui, Y. Maejima, and J. Pain Endogenous muscle atrophy F-box mediates pressure overload-induced cardiac hypertrophy through regulation of nuclear factor-kappa B Circ Res 109 2011 161 171
56. H.L. Narver, L. Kong, and B.G. Burnett Sustained improvement of spinal muscular atrophy mice treated with trichostatin A plus nutrition Ann Neurol 64 2008 465 470
57. C. Boyault, Y. Zhang, and S. Fritah HDAC6 controls major cell response pathways to cytotoxic accumulation of protein aggregates Genes Dev 21 2007 2172 2181
58. P.O. Hasselgren, C. Wray, and J. Mammen Molecular regulation of muscle cachexia: it may be more than the proteasome Biochem Biophys Res Commun 290 2002 1 10
59. C. Boyault, K. Sadoul, and M. Pabion HDAC6, at the crossroads between cytoskeleton and cell signaling by acetylation and ubiquitination Oncogene 26 2007 5468 5476
60. R.M. Dai, E. Chen, and D.L. Longo Involvement of valosin-containing protein, an ATPase co-purified with IkBα and 26S proteasome, in ubiquitin-proteasome-mediated degradation of IkBα J Biol Chem 273 1998 3562 3573
61. N. Alamdari, Z. Aversa, and E. Castillero Resveratrol prevents dexamethasone-induced expression of the muscle atrophy-related ubiquitin ligases atrogin-1 and MuRF1 in cultured myotubes through a SIRT1-dependent mechanism Biochem Biophys Res Commun 417 2012 528 533
62. K. Balasubramanyam, R.A. Varier, and M. Altaf Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, suppresses the acetylation of histone/nonhistone proteins and histone acetyltransferase- dependent chromatin transcription J Biol Chem 279 2004 51163 51171
63. T. Morimoto, Y. Sunagawa, and T. Kawamura The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats J Clin Invest 118 2008 868 878
64. K. Balasubramanyam, M. Altaf, and R.A. Varier Polyisoprenylated benzophenone, garcinol, a natural histone acetyltransferase inhibitor, represses chromatin transcription and alters global gene expression J Biol Chem 279 2004 33716 33726
65. K. Mantelingu, B.A.A. Reddy, and V. Swaminathan Specific inhibition of p300-HAT alters global gene expression and represses HIV replication Chem Biol 14 2007 645 657
66. M. Ghizzoni, A. Boltjes, and C. de Graaf Improved inhibition of the histone acetyltransferase PCAF by an anacardic acid derivative Bioorg Med Chem 18 2010 5826 5834
67. V. Poylin, M.U. Fareed, and P. O'Neal The NF-kB inhibitor curcumin blocks sepsis-induced muscle proteolysis Mediat Inflam 2008 2008 317851
68. N. Alamdari, P. O'Neal, and P.O. Hasselgren Curcumin and muscle wasting - a new role for an old drug? Nutrition 25 2009 125 129
69. O.D. Lau, A.D. Courtney, and A. Vassilev p300/CBP-associated factor histone acetyltransferase processing of a peptide substrate. Kinetic analysis of the catalytic mechanism J Biol Chem 275 2000 1953 1959
70. E.M. Bowers, G. Yan, and C. Mukherjee Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor Chem Biol 17 2010 471 482
71. J.C. Milne, P.D. Lambert, and S. Schenk Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes Nature 450 2007 712 716
72. G.J. Soleas, E.P. Diamandis, and D.M. Goldberg The world of resveratrol Adv Exp Med Biol 492 2001 159 182
73. J. Burns, T. Yokota, and H. Ashikara Plant foods and herbal sources of resveratrol J Agric Food Chem 50 2002 3337 3340
74. M.T. Borra, B.C. Smith, and J.M. Denn Mechanism of human SIRT1 activation by resveratrol J Biol Chem 280 2005 17187 17195
75. J.R. Jackson, M.J. Ryan, and Y. Hao Mediation of endogenous antioxidant enzymes and apoptotic signaling by resveratrol following muscle disuse in the gastrocnemius muscles of young and old rats Am J Physiol Regul Integr Comp Physiol 299 2010 R1572 R1581
76. M. Holmes-McNary, and A.S. Baldwin Chemo-preventive properties of trans-resveratrol are associated with inhibition of activation of the IkB kinase Cancer Res 60 2000 3477 3483
77. C. Centeno-Baez, P. Dallaire, and A. Marette Resveratrol inhibition of inducible nitric oxide synthase in skeletal muscle involves AMPK but not SIRT1 Am J Physiol Endocrinol Metab 301 2011 E922 E930
78. J.A. Baur, K.J. Pearson, and N.L. Price Resveratrol improves health and survival of mice on a high-calorie diet Nature 444 2006 337 342
79. M. Lagouge, C. Argmann, and Z. Gerhart-Hines Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α Cell 127 2006 1109 1122
80. I. Momken, L. Stevens, and A. Bergouignan Resveratrol prevents the wasting disorders of mechanical unloading by acting as a physical exercise mimetic in the rat FASEB J 25 2011 3646 3660
81. L.L. Chen, H.H. Zhang, and J. Zheng Resveratrol attenuates high-fat diet-induced insulin resistance by influencing skeletal muscle lipid transport and subsarcolemmal mitochondrial β-oxidation Metabolism 60 2011 1598 1609
82. W. Kang, H.J. Hong, and J. Guan Resveratrol improves insulin signaling in a tissue-specific manner under insulin-resistant conditions only: in vitro and in vivo experiments in rodents Metabolism 61 2012 424 433
83. S.H. Lee, C. Mantzoros, and Y.B. Kim Resveratrol: is selectivity opening the key to therapeutic effects? Metabolism 61 2012 289 290
84. T.N. Stitt, D. Drujan, and B.A. Clarke The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting Foxo transcription factors Mol Cell 14 2004 395 403
85. I. Smith, N. Alamdari, and P. O'Neal Sepsis increases the expression and activity of the transcription factor forkhead box O 1 (FOXO1) in skeletal muscle by a glucocorticoid-dependent mechanism Int J Biochem Cell Biol 42 2010 701 711
86. C. Mammacuri, S. Schiaffino, and M. Sandri Downstream of Akt: FoxO3 and mTOR in the regulation of autophagy in skeletal muscle Autophagy 4 2008 524 526
87. H. Yang, J. Mammen, and W. Wei The expression and activity of C/EBPβ and δ are upregulated by dexamethasone in skeletal muscle J Cell Physiol 204 2005 219 226
88. P. Gonnella, N. Alamdari, and S. Tizio C/EBPβ regulates dexamethasone-induced muscle cell atrophy and expression of atrogin-1 and MuRF1 J Cell Biochem 112 2011 1737 1748
89. G. Zhang, B. Jin, and Y.P. Li C/EBPβ mediates tumour-induced ubiquitin ligase atrogin-1/MAFbx upregulation and muscle wasting EMBO J 30 2011 4323 4335
90. C.G. Penner, G. Gang, and C. Wray The transcription factors NF-kB and AP-1 are differentially regulated in skeletal muscle during sepsis Biochem Biophys Res Commun 281 2001 1331 1336
91. Y.P. Li, and M.B. Reid NF-kB mediates the protein loss induced by TNF-α in differentiated skeletal muscle myotubes Am J Physiol Regul Integr Comp Physiol 279 2000 R1165 R1170
92. K.J. Ladner, M.A. Caligiuri, and D.C. Guttridge Tumor necrosis factor-regulated biphasic activation of NF-kB is required for cytokine-induced loss of skeletal muscle gene products J Biol Chem 278 2003 2294 2303
93. D. Van Gammeren, J.S. Damrauer, and R.W. Jackman The IkB kinases IKKα and IKKβ are necessary and sufficient for skeletal muscle atrophy FASEB J 23 2009 362 370
94. A. Brunet, L.B. Sweeney, and J.F. Sturgill Stress-dependent regulation of FoxO transcription factors by the Sirt1 deacetylase Science 303 2004 2011 2015
95. B.S. An, L.E. Tavera-Mendoza, and V. Dimitrov Stimulation of Sirt1-regulated FoxO protein function by the ligand-bound vitamin D receptor Mol Cell Biol 30 2010 4890 4900
96. M. Fukuoka, H. Daitoku, and M. Hatta Negative regulation of fork head transcription factor AFX (FOXO4) by CBP-induced acetylation Int J Mol Med 12 2003 503 508
97. L.P. Van der Heide, and M.P. Smidt Regulation of FoxO activity by CBP/p300-mediated acetylation Trends Biochem Sci 30 2005 81 86
98. E. Bertaggia, L. Coletto, and M. Sandri Posttranslational modifications control FoxO3 activity during denervation Am J Physiol Cell Physiol 302 2012 C587 C596
99. M.C. Motta, N. Divecha, and M. Lemieux Mammalian SIRT1 represses forkhead transcription factors Cell 116 2004 551 563
100. Y. Yang, H. Hon, and E.M. Haller Suppression of FOXO1 activity by FHL2 through SIRT1-mediated deacetylation EMBO J 24 2005 1021 1032
101. H. Daitoku, J. Sakamaki, and A. Fukamizu Regulation of FoxO transcription factors by acetylation and protein-protein interactions Biochim Biophys Acta 1813 2011 1954 1960
102. N. Hariharan, Y. Maejima, and J. Nakae Deacetylation of FoxO by Sirt1 plays an essential role in mediating starvation-induced autophagy in cardiac myocytes Circ Res 107 2010 1 13
103. G. Penner, G. Gang, and X. Sun C/EBP DNA binding activity is upregulated by a glucocorticoid-dependent mechanism in septic muscle Am J Physiol Regul Integr Comp Physiol 282 2002 R439 R444
104. N. Wiper-Bergeron, D. Wu, and L. Pope Stimulation of preadipocyte differentiation by steroid through targeting of an HDAC1 complex EMBO J 22 2003 2135 2145
105. N. Wiper-Bergeron, H. Abdon Salem, and J. Tomlinson Glucocorticoid- stimulated preadipocyte differentiation is mediated through acetylation of C/EBPβ by GCN5 Proc Natl Acad Sci USA 104 2007 2703 2708
106. H. Jeong, F. Then, and T.J. Melia Acetylation targets mutant huntingtin to autophagosomes for degradation Cell 137 2009 60 72
107. L. Galbiati, R. Mendoza-Maldonado, and M.I. Gutierrez Regulation of E2F-1 after DNA damage by p300-mediated acetylation and ubiquitination Cell Cycle 4 2005 930 939
108. S. Iezzi, G. Cossu, and C. Nervi Stage-specific modulation of skeletal myogenesis by inhibitors of nuclear deacetylases Proc Natl Acad Sci USA 99 2002 7757 7762
109. G.C. Minetti, C. Colussi, and R. Adami Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors Nat Med 12 2006 1147 1150
110. T.J. Cohen, D.S. Waddell, and T. Barrientos The histone deacetylase HDAC4 connects neural activity to muscle transcriptional reprogramming J Biol Chem 282 2007 33752 33759
111. H. Tang, P. Macpherson, and M. Marvin A histone deacetylase 4/myogenin positive feed back loop coordinates denervation gene induction and suppression Mol Biol Cell 20 2009 1120 1131
112. V. Moresi, A.H. Williams, and E. Meadows Myogenin and class II HDACs control neurogenic muscle atrophy by inducing E3 ubiquitin ligases Cell 143 2010 35 45
113. S.L. McGee, E. Fairlie, and A.P. Garnham Exercise-induced histone modifications in human skeletal muscle J Physiol 587.24 2009 5951 5958
114. S.M. Senf, P.B. Sandesara, and S.A. Reed p300 acetyltransferase activity differentially regulates the localization and activity of the FOXO homologues in skeletal muscle Am J Physiol Cell Physiol 300 2011 C1490 C1501
115. P.O. Hasselgren, J.H. James, and D.W. Benson Total and myofibrillar protein breakdown in different types of skeletal muscle: effects of sepsis and regulation by insulin Metabolism 38 1989 634 640